Médecins Sans Frontières

Tackling TB: Expand access to and improve affordability of diagnostics and treatment

Statement by the Treatment Action Campaign, SECTION27, Médecins Sans Frontières and Oxfam.

Read More →

MSF: Opportunity to transform medical innovation before health ministers

Medical innovation is not delivering for the needs of people in developing countries. 65th World Health Assembly to debate binding convention on R&D.

Read More →

From the ground up: Building a drug-resistant TB program in Uganda

Uganda is one of the world's 22 high burden countries for tuberculosis (TB). Despite having a national treatment program for drug-sensitive TB, there has been an emergence of drug-resistant strains of the disease, which are presenting a new and urgent threat to people's health. So far in Uganda, 226 cases of multidrug-resistant tuberculosis (MDR-TB) have been confirmed, spread across 40 districts, but the true figure is likely to be much higher.

Read More →

MSF: Open letter

Open letter to the Medicines Control Council of South Africa regarding compassionate use of bedaquiline for drug-resistant tuberculosis in South Africa.

Read More →

MSF: Alarming rate of drug-resistant tuberculosis cases in India requires heightened response

New Delhi, 23 March 2012 – The growing number of drug-resistant tuberculosis (DR-TB) cases in India, lends greater urgency to solve major problems surrounding the treatment of TB and regulation of TB drugs in the country’s private market, the international medical humanitarian organization Médecins Sans Frontières / Doctors Without Borders (MSF) said today, alongside the Peoples’ Health Movement, Stop TB Partnership and Delhi Network of Positive People (DNP+).

Read More →

Page 8 of 8 · Total posts: 5

←First 7 8